Hematologic toxicity epirubicin. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy1

Diseases43

Hematologic Diseases Leukopenia Neutropenia Thrombocytopenia Breast Neoplasms Lung Neoplasms Nausea Neoplasm Recurrence, Local Neoplasm Metastasis Neoplasms Carcinoma, Small Cell Lymphoma, Non-Hodgkin Adenocarcinoma Vomiting Agranulocytosis Disease Progression Ovarian Neoplasms Anemia Carcinoma, Non-Small-Cell Lung Stomach Neoplasms Peritoneal Neoplasms Bone Marrow Diseases Bone Neoplasms Alopecia Radiation Injuries Fallopian Tube Neoplasms Colorectal Neoplasms Sarcoma Brain Neoplasms Liver Neoplasms Carcinoma Carcinoma, Transitional Cell Pancreatic Neoplasms Fatigue Hodgkin Disease Gastrointestinal Diseases Stomatitis Glioma Recurrence Lymphoma, B-Cell Rectal Neoplasms Carcinoma, Squamous Cell Head and Neck Neoplasms

Chemicals and Drugs61

Epirubicin Fluorouracil Cyclophosphamide Cisplatin Deoxycytidine Paclitaxel Taxoids Antibiotics, Antineoplastic Doxorubicin Carboplatin Antineoplastic Agents Etoposide Ifosfamide Antineoplastic Agents, Phytogenic Granulocyte Colony-Stimulating Factor Vinblastine Topotecan Vincristine Antimetabolites, Antineoplastic Organoplatinum Compounds Methotrexate Antineoplastic Agents, Alkylating Camptothecin Leucovorin Razoxane Dacarbazine Yttrium Radioisotopes Prednisone Antibodies, Monoclonal Anthracyclines Bleomycin Amifostine Nitrogen Mustard Compounds Mitomycin Iodine Radioisotopes Radioisotopes Tegafur Platinum Antibodies, Monoclonal, Humanized Recombinant Proteins 3-Iodobenzylguanidine Boronic Acids Antibodies, Monoclonal, Murine-Derived Polyethylene Glycols Pyrazines Prolyl Hydroxylases Melphalan Guanine Oxonic Acid Organometallic Compounds Glutamates Cytarabine Radiopharmaceuticals Thalidomide Vidarabine Antigens, CD20 Zidovudine Naphthacenes Interferon-alpha Granulocyte-Macrophage Colony-Stimulating Factor Receptor, erbB-2

Analytical, Diagnostic and Therapeutic Techniques and Equipment42

Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Treatment Outcome Infusions, Intravenous Disease-Free Survival Radioimmunotherapy Maximum Tolerated Dose Survival Analysis Combined Modality Therapy Survival Rate Chemotherapy, Adjuvant Drug Evaluation Toxicity Tests Neoplasm Staging Radiotherapy Dosage Neoadjuvant Therapy Platelet Count Remission Induction Administration, Oral Salvage Therapy Leukocyte Count Area Under Curve Feasibility Studies Follow-Up Studies Toxicity Tests, Acute Injections, Intravenous Radiometry Prospective Studies Prognosis Kaplan-Meier Estimate Blood Cell Count Dose Fractionation Retrospective Studies Pilot Projects Drug Therapy, Combination Injections, Subcutaneous Hyperthermia, Induced Dose-Response Relationship, Radiation Clinical Trials as Topic Lethal Dose 50 Random Allocation Hematopoietic Stem Cell Transplantation

Phenomena and Processes10

Dose-Response Relationship, Drug Maximum Tolerated Dose Platelet Count Leukocyte Count Area Under Curve Drug Resistance, Neoplasm Time Factors Blood Cell Count Dose-Response Relationship, Radiation Lethal Dose 50

Anthropology, Education, Sociology and Social Phenomena1

Quality of Life

Technology, Industry, Agriculture1

Polyethylene Glycols

Humanities1

Quality of Life

Information Science1

Health Care15

Treatment Outcome Disease-Free Survival Survival Analysis Survival Rate Area Under Curve Feasibility Studies Follow-Up Studies Prospective Studies Radiation Injuries Kaplan-Meier Estimate Retrospective Studies Pilot Projects Dose-Response Relationship, Radiation Clinical Trials as Topic Random Allocation

Anatomy Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Anthropology, Education, Sociology and Social Phenomena Technology, Industry, Agriculture Humanities Information Science Health Care

Epirubicin Antineoplastic Combined Chemotherapy Protocols Drug Administration Schedule Hematologic Diseases Leukopenia Fluorouracil Cyclophosphamide Cisplatin Neutropenia Treatment Outcome Infusions, Intravenous Thrombocytopenia Deoxycytidine Paclitaxel Taxoids Antibiotics, Antineoplastic Doxorubicin Breast Neoplasms Disease-Free Survival Carboplatin Antineoplastic Agents Radioimmunotherapy Etoposide Dose-Response Relationship, Drug Maximum Tolerated Dose Survival Analysis Ifosfamide Antineoplastic Agents, Phytogenic Combined Modality Therapy Survival Rate Chemotherapy, Adjuvant Drug Evaluation Granulocyte Colony-Stimulating Factor Vinblastine Topotecan Vincristine Antimetabolites, Antineoplastic Toxicity Tests Organoplatinum Compounds Methotrexate Lung Neoplasms Neoplasm Staging Nausea Antineoplastic Agents, Alkylating Neoplasm Recurrence, Local Camptothecin Neoplasm Metastasis Neoplasms Leucovorin Radiotherapy Dosage Carcinoma, Small Cell Neoadjuvant Therapy Platelet Count Remission Induction Administration, Oral Razoxane Lymphoma, Non-Hodgkin Adenocarcinoma Vomiting Dacarbazine Yttrium Radioisotopes Salvage Therapy Prednisone Leukocyte Count Agranulocytosis Area Under Curve Disease Progression Antibodies, Monoclonal Drug Resistance, Neoplasm Ovarian Neoplasms Anemia Carcinoma, Non-Small-Cell Lung Feasibility Studies Follow-Up Studies Toxicity Tests, Acute Stomach Neoplasms Injections, Intravenous Anthracyclines Bleomycin Amifostine Peritoneal Neoplasms Time Factors Bone Marrow Diseases Nitrogen Mustard Compounds Bone Marrow Bone Neoplasms Radiometry Mitomycin Prospective Studies Iodine Radioisotopes Radioisotopes Tegafur Alopecia Platinum Radiation Injuries Antibodies, Monoclonal, Humanized Fallopian Tube Neoplasms Prognosis Recombinant Proteins Colorectal Neoplasms

No FAQ available that match "hematologic toxicity epirubicin"